Naratriptan

FDA Approved: * July 7, 2010
Pharm Company: * ROXANE
Category: Migraine / Tension Headache

Naratriptan (trade names include Amerge) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT1 receptor subtype agonist. It was patented in 1987 and approved for medical use in 1997.[1] Contents 1 Medical uses 1.1 Efficacy 2 Side effects 3 Mechanism of action 4 Society and culture 5 References Medical uses Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migrai... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Naratriptan 54;351
Naratriptan (As Naratriptan Hydrochloride) 2.5 mg Oral Tablet
NDC: 0054-0279
Labeler:
Roxane Laboratories, Inc.
Naratriptan PAD;214
Naratriptan (As Naratriptan Hydrochloride) 1 mg Oral Tablet
NDC: 0574-0214
Labeler:
Paddock Laboratories, Inc.
Naratriptan I53
Naratriptan (As Naratriptan Hydrochloride) 1 mg Oral Tablet
NDC: 23155-054
Labeler:
Heritage Pharmaceuticals Inc.
Naratriptan I54
Naratriptan (As Naratriptan Hydrochloride) 2.5 mg Oral Tablet
NDC: 23155-055
Labeler:
Heritage Pharmaceuticals Inc.
Naratriptan (As Naratriptan Hydrochloride) 1 mg Oral Tablet
NDC: 0054-0278
Labeler:
Roxane Laboratories, Inc.
Naratriptan (As Naratriptan Hydrochloride) 1 mg Oral Tablet
NDC: 0093-8522
Labeler:
Teva Pharmaceuticals USA Inc
Naratriptan (As Naratriptan Hydrochloride) 2.5 mg Oral Tablet
NDC: 0093-8523
Labeler:
Teva Pharmaceuticals USA Inc
Naratriptan (As Naratriptan Hydrochloride) 1 mg Oral Tablet
NDC: 0378-4450
Labeler:
Mylan Pharmaceuticals Inc.
Naratriptan (As Naratriptan Hydrochloride) 2.5 mg Oral Tablet
NDC: 0378-4451
Labeler:
Mylan Pharmaceuticals Inc.
Naratriptan (As Naratriptan Hydrochloride) 2.5 mg Oral Tablet
NDC: 0574-0215
Labeler:
Paddock Laboratories, Inc.
More Results

Related Brands

Drugs with the same active ingredients